Found 4 matching trials
A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases PHASE2 This study evaluates the efficacy and safety of SRT combined with pyrotinib...
Show More Location
Jiangxi Cancer Hospital of Nanchang University
Learn More & Join Trial
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases PHASE1 Brain metastases occur in 30-50% of patients with metastatic HER2-positive ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases PHASE2 A total of 224 subjects of HER2-positive advanced breast cancer with brain ...
Show More Learn More & Join Trial
Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases PHASE2 This is a prospective, open-label, exploratory clinical trial designed to e...
Show More Location
Nanfang Hospital, Southern Medical University
Learn More & Join Trial